These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15066891)

  • 1. Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1).
    Williams NM; Preece A; Morris DW; Spurlock G; Bray NJ; Stephens M; Norton N; Williams H; Clement M; Dwyer S; Curran C; Wilkinson J; Moskvina V; Waddington JL; Gill M; Corvin AP; Zammit S; Kirov G; Owen MJ; O'Donovan MC
    Arch Gen Psychiatry; 2004 Apr; 61(4):336-44. PubMed ID: 15066891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression.
    Bray NJ; Preece A; Williams NM; Moskvina V; Buckland PR; Owen MJ; O'Donovan MC
    Hum Mol Genet; 2005 Jul; 14(14):1947-54. PubMed ID: 15917270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying potential risk haplotypes for schizophrenia at the DTNBP1 locus in Han Chinese and Scottish populations.
    Li T; Zhang F; Liu X; Sun X; Sham PC; Crombie C; Ma X; Wang Q; Meng H; Deng W; Yates P; Hu X; Walker N; Murray RM; St Clair D; Collier DA
    Mol Psychiatry; 2005 Nov; 10(11):1037-44. PubMed ID: 16044171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families.
    van den Oord EJ; Sullivan PF; Jiang Y; Walsh D; O'Neill FA; Kendler KS; Riley BP
    Mol Psychiatry; 2003 May; 8(5):499-510. PubMed ID: 12808430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder.
    Green EK; Raybould R; Macgregor S; Gordon-Smith K; Heron J; Hyde S; Grozeva D; Hamshere M; Williams N; Owen MJ; O'Donovan MC; Jones L; Jones I; Kirov G; Craddock N
    Arch Gen Psychiatry; 2005 Jun; 62(6):642-8. PubMed ID: 15939841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria.
    Kirov G; Ivanov D; Williams NM; Preece A; Nikolov I; Milev R; Koleva S; Dimitrova A; Toncheva D; O'Donovan MC; Owen MJ
    Biol Psychiatry; 2004 May; 55(10):971-5. PubMed ID: 15121479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis.
    Kishimoto M; Ujike H; Motohashi Y; Tanaka Y; Okahisa Y; Kotaka T; Harano M; Inada T; Yamada M; Komiyama T; Hori T; Sekine Y; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
    Biol Psychiatry; 2008 Jan; 63(2):191-6. PubMed ID: 17555717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dysbindin gene (DTNBP1) and schizophrenia: no support for an association in the Korean population.
    Joo EJ; Lee KY; Jeong SH; Ahn YM; Koo YJ; Kim YS
    Neurosci Lett; 2006 Oct; 407(2):101-6. PubMed ID: 16959423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genetic variation in the dysbindin gene (DTNBP1) is associated with memory performance in healthy controls.
    Hashimoto R; Noguchi H; Hori H; Nakabayashi T; Suzuki T; Iwata N; Ozaki N; Kosuga A; Tatsumi M; Kamijima K; Harada S; Takeda M; Saitoh O; Kunugi H
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):431-8. PubMed ID: 19353385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients.
    Pae CU; Drago A; Kim JJ; Patkar AA; Jun TY; Lee C; Mandelli L; De Ronchi D; Paik IH; Serretti A
    Neurosci Lett; 2008 Aug; 440(2):150-4. PubMed ID: 18562100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confirmation and refinement of an 'at-risk' haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the Neuregulin-1 locus.
    Corvin AP; Morris DW; McGhee K; Schwaiger S; Scully P; Quinn J; Meagher D; Clair DS; Waddington JL; Gill M
    Mol Psychiatry; 2004 Feb; 9(2):208-13. PubMed ID: 14966480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction.
    Vilella E; Costas J; Sanjuan J; Guitart M; De Diego Y; Carracedo A; Martorell L; Valero J; Labad A; De Frutos R; Nájera C; Moltó MD; Toirac I; Guillamat R; Brunet A; Vallès V; Pérez L; Leon M; de Fonseca FR; Phillips C; Torres M
    J Psychiatr Res; 2008 Mar; 42(4):278-88. PubMed ID: 17408693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dysbindin risk haplotype associated with less severe manic-type symptoms in psychosis.
    Corvin A; Donohoe G; Nangle JM; Schwaiger S; Morris D; Gill M
    Neurosci Lett; 2008 Jan; 431(2):146-9. PubMed ID: 18162312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early visual processing deficits in dysbindin-associated schizophrenia.
    Donohoe G; Morris DW; De Sanctis P; Magno E; Montesi JL; Garavan HP; Robertson IH; Javitt DC; Gill M; Corvin AP; Foxe JJ
    Biol Psychiatry; 2008 Mar; 63(5):484-9. PubMed ID: 17945199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study of the dysbindin (DTNBP1) gene in schizophrenia from the Japanese population.
    Tochigi M; Zhang X; Ohashi J; Hibino H; Otowa T; Rogers M; Kato T; Okazaki Y; Kato N; Tokunaga K; Sasaki T
    Neurosci Res; 2006 Oct; 56(2):154-8. PubMed ID: 16876895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of three strong candidate schizophrenia susceptibility genes in demographically distinct populations.
    Hall D; Gogos JA; Karayiorgou M
    Genes Brain Behav; 2004 Aug; 3(4):240-8. PubMed ID: 15248869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory.
    Cannon TD; Hennah W; van Erp TG; Thompson PM; Lonnqvist J; Huttunen M; Gasperoni T; Tuulio-Henriksson A; Pirkola T; Toga AW; Kaprio J; Mazziotta J; Peltonen L
    Arch Gen Psychiatry; 2005 Nov; 62(11):1205-13. PubMed ID: 16275808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysbindin modulates brain function during visual processing in children.
    Mechelli A; Viding E; Kumar A; Pettersson-Yeo W; Fusar-Poli P; Tognin S; O'Donovan MC; McGuire P
    Neuroimage; 2010 Jan; 49(1):817-22. PubMed ID: 19631276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixture model clustering of phenotype features reveals evidence for association of DTNBP1 to a specific subtype of schizophrenia.
    Wessman J; Paunio T; Tuulio-Henriksson A; Koivisto M; Partonen T; Suvisaari J; Turunen JA; Wedenoja J; Hennah W; Pietiläinen OP; Lönnqvist J; Mannila H; Peltonen L
    Biol Psychiatry; 2009 Dec; 66(11):990-6. PubMed ID: 19782967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DTNBP1, NRG1, DAOA, DAO and GRM3 polymorphisms and schizophrenia: an association study.
    Jönsson EG; Saetre P; Vares M; Andreou D; Larsson K; Timm S; Rasmussen HB; Djurovic S; Melle I; Andreassen OA; Agartz I; Werge T; Hall H; Terenius L
    Neuropsychobiology; 2009; 59(3):142-50. PubMed ID: 19439994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.